Search This Blog

Tuesday, August 6, 2019

Aurinia Pharma EPS misses by $0.01, revenue in-line

Aurinia Pharma (NASDAQ:AUPH): Q2 GAAP EPS of -$0.17 misses by $0.01.
Revenue of $0.03M in-line (flat Y/Y).
Shares -0.33%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)